Regeneron Stock – Alexion Pharmaceuticals Inc. stock falls Monday, underperforms market
Shares of Alexion Pharmaceuticals Inc.
slid 0.47% to $176.28 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index
falling 0.08% to 4,226.52 and Dow Jones Industrial Average
falling 0.36% to 34,630.24. The stock’s fall snapped a two-day winning streak. Alexion Pharmaceuticals Inc. closed $2.84 short of its 52-week high ($179.12), which the company achieved on May 20th.
The stock underperformed when compared to some of its competitors Monday, as Gilead Sciences Inc.
fell 0.01% to $67.42, Vertex Pharmaceuticals Inc.
fell 0.37% to $209.16, and Regeneron Pharmaceuticals Inc.
rose 0.61% to $514.99. Trading volume (3.3 M) eclipsed its 50-day average volume of 2.0 M.